Imagine a room where America’s most sought-after market access decision makers have gathered for all your questions
WE GET YOU IN THAT ROOM
We created Formulary Insights to help biopharmaceutical investors, marketers, and leaders better understand and anticipate payer and specialty pharmacy perceptions of every therapeutic area.
WHAT WE DO
We only provide you with insights from
real decision makers
No retirees,
no loose affiliations,
no misrepresentations
OUR UNIQUE VALUE PROPOSITION
OUR PANEL
Only FORMULARY INSIGHTS can identify active market access decision makers
OUR SPEED
Actionable insights in weeks not months
OUR PEOPLE
Insights interpreted only by those who’ve been there before
May 14, 2020 | John Fox and Mark O'Neill
Payers have transformed the competitive marketplace, and biopharma companies need to regain their position as the authority on their products. To do this, they must establish new ways to anticipate, identify, and react to payer impressions of relevant evidence as they occur.
NO RETIREES, NO LOOSE AFFILIATIONS, NO MISREPRESENTATIONS
All our panelists are active decision makers
OUR MOST POPULAR OFFERINGS
FIRST
The answers you need. From the payers you want. In time to act.
DIRECT INQUIRY
Your opportunity for exhaustive research on key areas of interest
A single-study deep-dive to ensure a complete understanding of payer interests and impressions
SYNDICATED RESEARCH
All the benefits of our Direct Inquiry studies without the compliance requirements of developing your own
TESTIMONIALS
Pre-launch Study Evaluations gave us the insights that informed Phase 3 study design in time for us to include critical payer endpoints.
CONTACT US
There finally is a better way.
Get REAL insights from ACTIVE formulary decision makers in time to act.
We are ready to go to work for you today.
